DDX5 and pancreatic neoplasm: Furthermore, Li et al. demonstrated that FL118 degrades the DDX5 in pancreatic cancer Mia Paca-2 and Panc-1 cells and colorectal cancer SW620 cells through the ubiquitin–proteasome degradation pathway, without decreasing the DDX5 mRNA level [133].